Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1
The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
A Trial Assessing Several Schedules of Oral S-1 in Combination With a Fixed Dose of Oxaliplatin and Irinotecan
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
- Status
- SUSPENDED
- Phase
- PHASE4
Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach Cancer
- Status
- COMPLETED
- Phase
- PHASE1
XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Hepatic Arterial Infusion With FOLFOX Alone or in Combination With IV Chemotherapy in Colon Cancer With Liver Metastasis
- Status
- WITHDRAWN
- Phase
- PHASE2
Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study
- Status
- TERMINATED
- Phase
- PHASE2
C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Folfoxiri Plus Bev Followed by Reintroduction of Folfoxiri Plus Bev at Progression Versus Folfox Plus Bev Followed by Folfiri Plus Bev in mCRC
- Status
- UNKNOWN
- Phase
- PHASE3
Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers
- Status
- WITHDRAWN
- Phase
- PHASE2
CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE3